Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses

被引：2
作者：
Awad, Ahmed M. [1 ]
Hansen, Kamryn [1 ]
Del Rio, Diana [1 ]
Flores, Derek [1 ]
Barghash, Reham F. [2 ]
Kakkola, Laura [3 ]
Julkunen, Ilkka [3 ,4 ]
Awad, Kareem [3 ,5 ]
机构：
[1] Calif State Univ Channel Isl, Dept Chem, Camarillo, CA 93012 USA
[2] Inst Chem Ind Res, Natl Res Ctr, Cairo 12622, Egypt
[3] Univ Turku, Inst Biomed, Fac Med, Turku 20014, Finland
[4] Turku Univ Hosp, Clin Microbiol, Turku 20521, Finland
[5] Natl Res Ctr, Inst Pharmaceut & Drug Ind Res, Dept Therapeut Chem, Cairo 12622, Egypt
来源：
BIOMOLECULES | 2023年 / 13卷 / 10期
关键词：
coronavirus; COVID-19; target cell responses; drug design; nucleoside analogs; ACE2; RESPIRATORY SYNDROME CORONAVIRUS; VIRAL DISEASES; EBOLA-VIRUS; MERS-COV; SARS-COV-2; SARS; INFECTION; PATHOGENESIS; RIBAVIRIN; EFFICACY;
D O I：
10.3390/biom13101452
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In light of the COVID-19 global pandemic caused by SARS-CoV-2, ongoing research has centered on minimizing viral spread either by stopping viral entry or inhibiting viral replication. Repurposing antiviral drugs, typically nucleoside analogs, has proven successful at inhibiting virus replication. This review summarizes current information regarding coronavirus classification and characterization and presents the broad clinical consequences of SARS-CoV-2 activation of the angiotensin-converting enzyme 2 (ACE2) receptor expressed in different human cell types. It provides publicly available knowledge on the chemical nature of proposed therapeutics and their target biomolecules to assist in the identification of potentially new drugs for the treatment of SARS-CoV-2 infection.
引用
收藏
页数：28
相关论文
共 228 条
  • [1] Gastrointestinal and Liver Manifestations of COVID-19
    Agarwal, Amol
    Chen, Alan
    Ravindran, Nishal
    To, Chau
    Thuluvath, Paul J.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (03) : 263 - 265
  • [2] Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
    Agostini, Maria L.
    Pruijssers, Andrea J.
    Chappell, James D.
    Gribble, Jennifer
    Lu, Xiaotao
    Andres, Erica L.
    Bluemling, Gregory R.
    Lockwood, Mark A.
    Sheahan, Timothy P.
    Sims, Amy C.
    Natchus, Michael G.
    Saindane, Manohar
    Kolykhalov, Alexander A.
    Painter, George R.
    Baric, Ralph S.
    Denison, Mark R.
    [J]. JOURNAL OF VIROLOGY, 2019, 93 (24)
  • [3] Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
    Aguilar-Valles, Argel
    Haji, Nabila
    De Gregorio, Danilo
    Matta-Camacho, Edna
    Eslamizade, Mohammad J.
    Popic, Jelena
    Sharma, Vijendra
    Cao, Ruifeng
    Rummel, Christoph
    Tanti, Arnaud
    Wiebe, Shane
    Nunez, Nicolas
    Comai, Stefano
    Nadon, Robert
    Luheshi, Giamal
    Mechawar, Naguib
    Turecki, Gustavo
    Lacaille, Jean-Claude
    Gobbi, Gabriella
    Sonenberg, Nahum
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [4] Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
    Ahsan, Tamim
    Sajib, Abu Ashfaqur
    [J]. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 26
  • [5] RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19
    Ajmera, Veeral
    Thompson, Wesley K.
    Smith, Davey M.
    Malhotra, Atul
    Mehta, Ravindra L.
    Tolia, Vaishal
    Yin, Jeffrey
    Sriram, Krishna
    Insel, Paul A.
    Collier, Summer
    Richards, Lisa
    Loomba, Rohit
    [J]. CONTEMPORARY CLINICAL TRIALS, 2021, 103
  • [6] Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2
    Al-Khafaji, Khattab
    AL-DuhaidahawiL, Dunya
    Taskin Tok, Tugba
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (09) : 3387 - 3395
  • [7] Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
    Al-Tawfiq, Jaffar A.
    Momattin, Hisham
    Dib, Jean
    Memish, Ziad A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 20 : 42 - 46
  • [8] Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
    Angel Martinez, Miguel
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
  • [9] Is the kidney a target of SARS-CoV-2?
    Angel Martinez-Rojas, Miguel
    Vega-Vega, Olynka
    Bobadilla, Norma A.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 318 (06) : F1454 - F1462
  • [10] [Anonymous], 2020, COR COVID 19 UPD FDA
12345678910